BIOPLUS ACQUISITION CORP.
| General Information | |
| Business: | We intend to focus our search on companies in the life sciences industry. We shall not undertake our initial business combination with any entity with its principal business operations in China (including Hong Kong and Macau). (Incorporated in the Cayman Islands) (Note: BioPlus Acquisition Corp. upsized its SPAC IPO at pricing on Dec. 2, 2021, to 20 million units, up from 18 million units, at $10 each to raise $200 million.) |
| Industry: | BLANK CHECKS |
| Employees: | 0 |
| Founded: | 2021 |
| Contact Information | |
| Address | 260 Madison Avenue Suite 800 New York, New York 10016 |
| Phone Number | (212) 287-4092 |
| Web Address | |
| View Prospectus: | BIOPLUS ACQUISITION CORP. |
| Financial Information | |
| Market Cap | $250.6mil |
| Revenues | $0 mil (last 12 months) |
| Net Income | $0 mil (last 12 months) |
| IPO Profile | |
| Symbol | BIOSU |
| Exchange | NASDAQ |
| Shares (millions): | 20.0 |
| Price range | $10.00 - $10.00 |
| Est. $ Volume | $200.0 mil |
| Manager / Joint Managers | Cantor Fitzgerald |
| CO-Managers | - |
| Expected To Trade: | 12/3/2021 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |